Severe Preeclampsia-Related Changes in Gene Expression at the Maternal-Fetal Interface Include Sialic Acid-Binding Immunoglobulin-Like Lectin-6 and Pappalysin-2
Open Access
- 25 September 2008
- journal article
- review article
- Published by The Endocrine Society in Endocrinology
- Vol. 150 (1), 452-462
- https://doi.org/10.1210/en.2008-0990
Abstract
Preeclampsia (PE), which affects 4–8% of human pregnancies, causes significant maternal and neonatal morbidity and mortality. Within the basal plate, placental cytotrophoblasts (CTBs) of fetal origin invade the uterus and extensively remodel the maternal vasculature. In PE, CTB invasion is often shallow, and vascular remodeling is rudimentary. To better understand possible causes, we conducted a global analysis of gene expression at the maternal-fetal interface in placental samples from women with PE (n = 12; 24–36 wk) vs. samples from women who delivered due to preterm labor with no evidence of infection (n = 11; 24–36 wk), a condition that our previous work showed is associated with normal CTB invasion. Using the HG-U133A&B Affymetrix GeneChip platform, and statistical significance set at log odds-ratio of B >0, 55 genes were differentially expressed in PE. They encoded proteins previously associated with PE [e.g. Flt-1 (vascular endothelial growth factor receptor-1), leptin, CRH, and inhibin] and novel molecules [e.g. sialic acid binding Ig-like lectin 6 (Siglec-6), a potential leptin receptor, and pappalysin-2 (PAPP-A2), a protease that cleaves IGF-binding proteins]. We used quantitative PCR to validate the expression patterns of a subset of the genes. At the protein level, we confirmed PE-related changes in the expression of Siglec-6 and PAPP-A2, which localized to invasive CTBs and syncytiotrophoblasts. Notably, Siglec-6 placental expression is uniquely human, as is spontaneous PE. The functional significance of these novel observations may provide new insights into the pathogenesis of PE, and assaying the circulating levels of these proteins could have clinical utility for predicting and/or diagnosing PE. Gene expression analysis of placental basal plates from severe preeclamptic pregnancies and controls revealed differential expression of 55 genes, including Siglec-6 and pappalysin-2.Keywords
This publication has 62 references indexed in Scilit:
- Comparative analysis of maternal-fetal interface in preeclampsia and preterm laborCell and tissue research, 2007
- SOCS3 Targets Siglec 7 for Proteasomal Degradation and Blocks Siglec 7-mediated ResponsesPublished by Elsevier BV ,2007
- Soluble Endoglin and Other Circulating Antiangiogenic Factors in PreeclampsiaThe New England Journal of Medicine, 2006
- Modification of the Standard Trizol-Based Technique Improves the Integrity of RNA Isolated from RNase-Rich Placental TissueClinical Chemistry, 2006
- Intracellular signalling pathways activated by leptinBiochemical Journal, 2005
- Uterine artery Doppler at 11–14 weeks of gestation to screen for hypertensive disorders and associated complications in an unselected populationUltrasound in Obstetrics & Gynecology, 2005
- Divergent metabolic and vascular phenotypes in pre-eclampsia and intrauterine growth restrictionJournal of Hypertension, 2004
- Chipping away at the chip bias: RNA degradation in microarray analysisNature Genetics, 2003
- OB-BP1/Siglec-6Published by Elsevier BV ,1999
- Dissection of the Domain Architecture of the α2macroglobulin‐Receptor‐Associated ProteinJBIC Journal of Biological Inorganic Chemistry, 1997